Harmony Biosciences Holdings Inc
For the period ended Dec 31, 2023. Filed Feb 22, 2024.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2023 · Filed Feb 22, 2024
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
SIGNATURES
Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
| | | | |
|---|---|---|---|
| | HARMONY BIOSCIENCES HOLDINGS, INC. | ||
| | | | |
| | By: | /s/ Jeffrey M. Dayno | |
| | Name: | Jeffrey M. Dayno | |
| | Title: | | |
| | | President, Chief Executive Officer and Director (principal executive officer) | |
**Date:**February 22, 2024
Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated:
| Signature | | Title | | Date |
|---|---|---|---|---|
| | | | | |
| /s/ Jeffrey M. Dayno | | President, Chief Executive Officer and Director | | February 22, 2024 |
| Jeffrey M. Dayno | | (Principal Executive Officer) | | |
| | | | | |
| /s/ Sandip Kapadia | | Chief Financial Officer and Chief Administrative Officer (Principal | | February 22, 2024 |
| Sandip Kapadia | | Financial Officer and Principal Accounting Officer) | | |
| | | | | |
| /s/ Jeffrey S. Aronin | | Chairman of the Board | | February 22, 2024 |
| Jeffrey S. Aronin | | | | |
| | | | | |
| /s/ Peter Anastasiou | | Director | | February 22, 2024 |
| Peter Anastasiou | | | | |
| | | | | |
| /s/ Antonio Gracias | | Director | | February 22, 2024 |
| Antonio Gracias | | | | |
| | | | | |
| /s/ R. Mark Graf | | Director | | February 22, 2024 |
| R. Mark Graf | | | | |
| | | | | |
| /s/ Jack Bech Nielsen | | Director | | February 22, 2024 |
| Jack Bech Nielsen | | | | |
| | | | | |
| /s/ Juan A. Sabater | | Director | | February 22, 2024 |
| Juan A. Sabater | | | | |
| | | | | |
| /s/ Gary Sender | | Director | | February 22, 2024 |
| Gary Sender | | | | |
| | | | | |
| /s/ Linda Szyper | | Director | | February 22, 2024 |
| Linda Szyper | | | | |
| | | | | |
| /s/ Andreas Wicki | | Director | | February 22, 2024 |
| Andreas Wicki | | | | |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.